Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Valeo Pharma Inc. Opens the Market

T.VPH

TORONTO, May 9, 2022 /CNW/ - Steve Saviuk, Chief Executive Officer, Frederic Fasano, President and Chief Operating Officer, Luc Mainville, Senior Vice-President and Chief Financial Officer, Valeo Pharma Inc. ("Valeo" or the "Company") (TSX: VPH) and their team joined Daniel Lubienietzky, Manager, Life Sciences, Toronto Stock Exchange, to celebrate the Company's new listing on Toronto Stock Exchange and open the market.

Headquartered in Kirkland, Quebec, Valeo Pharma is a Canadian specialty pharmaceutical company dedicated to the commercialization of innovative prescription products in Canada, with a focus on respirology, neurodegenerative diseases, oncology and other specialty products.

Date: Monday, May 9, 2022
Time: 9:00am - 9:30am
Place: 120 Adelaide St W.

SOURCE Toronto Stock Exchange

Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/May2022/09/c0042.html